Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial

Diabetes, Obesity & Metabolism
Mathias Ried-LarsenKristian Karstoft

Abstract

To investigate whether an intensive lifestyle intervention induces partial or complete type 2 diabetes (T2D) remission. In a secondary analysis of a randomized, assessor-blinded, single-centre trial, people with non-insulin-dependent T2D (duration <10 years), were randomly assigned (2:1, stratified by sex, from April 2015 to August 2016) to a lifestyle intervention group (n = 64) or a standard care group (n = 34). The primary outcome was partial or complete T2D remission, defined as non-diabetic glycaemia with no glucose-lowering medication at the outcome assessments at both 12 and 24 months from baseline. All participants received standard care, with standardized, blinded, target-driven medical therapy during the initial 12 months. The lifestyle intervention included 5- to 6-weekly aerobic and combined aerobic and strength training sessions (30-60 minutes) and individual dietary plans aiming for body mass index ≤25 kg/m2 . No intervention was provided during the 12-month follow-up period. Of the 98 randomized participants, 93 completed follow-up (mean [SD] age 54.6 [8.9] years; 46 women [43%], mean [SD] baseline glycated haemoglobin 49.3 [9.3] mmol/mol). At follow-up, 23% of participants (n = 14) in the intervention and 7% (n ...Continue Reading

References

Jan 25, 2003·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland
Apr 30, 2004·Statistics in Medicine·Michael J SweetingPaul C Lambert
Jul 15, 2004·American Journal of Physiology. Endocrinology and Metabolism·Flemming DelaHenrik Galbo
Oct 31, 2009·Diabetes Care·John B BuseM Sue Kirkman
Jan 15, 2011·Nature Reviews. Immunology·Marc Y Donath, Steven E Shoelson
Feb 9, 2011·BMJ : British Medical Journal·Ian R WhiteStuart J Pocock
Jan 5, 2013·JAMA : the Journal of the American Medical Association·Edward W GreggUNKNOWN Look AHEAD Research Group
May 24, 2014·Nature Reviews. Drug Discovery·Marc Y Donath
Sep 19, 2014·Diabetes Care·Andrew J KarterElbert S Huang
Nov 26, 2014·Nature Reviews. Rheumatology·Fabiana B Benatti, Bente K Pedersen
Jul 30, 2016·Medicine and Science in Sports and Exercise·Jessica L UnickRena R Wing
Aug 16, 2017·JAMA : the Journal of the American Medical Association·Mette Yun JohansenMathias Ried-Larsen
Dec 19, 2018·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Dec 19, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·C Y England, R C Andrews
Jul 22, 2020·Nature Reviews. Endocrinology·Faidon MagkosArne Astrup
Mar 27, 2021·Diabetes/metabolism Research and Reviews·Christopher S MacDonaldAmelia Barwise
Apr 25, 2021·Prilozi·Hira ShakoorLily Stojanovska
Aug 3, 2021·Frontiers in Nutrition·Sean D WheatleyTrudi E Reeves
Jul 30, 2021·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·Adrian BrownDuane Mellor
Nov 13, 2019·Metabolism: Clinical and Experimental·Chrysoula BoutariChristos S Mantzoros

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02417012

Software Mentioned

IC
STATA

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.